About Oxford Cardiovascular Science
Researchers across Oxford are working together at the forefront of cardiovascular science, with the overall goal of translating discoveries from the laboratory though to clinical practice. Our researchers will apply new cross cutting technologies to develop cardiovascular imaging and phenotyping, drug development, cardiac computer modelling and stem cell & gene therapy.
We have outstanding experience in conducting clinical trials and epidemiological studies as well as state-of-the-art basic science and clinical research facilities. We are particularly proud of our ability to bring together molecular, epidemiological and physiological research to understand cardiac and vascular disease right from the molecular level all the way up to the wider population.
The British Heart Foundation is a key sponsor of cardiovascular research in Oxford and the Centre of Research Excellence offers scientists across the city fantastic opportunities for research & training, supporting the current and next generation of leaders in Cardiovascular Science.
Cardiovascular Innovation Awards - call for Expressions of Interest
How to submit an expression of interest for the BHF Oxford CRE Cardiovascular Innovation Awards. Read more....
Past event highlights
BHF Oxford CRE Cardiovascular Innovation Awards kick-off event 2026
Bringing together researchers, investors, industry leaders, and entrepreneurs the event explored how academic discoveries can be transformed into real world patient impact.
BHF CRE Annual Symposium 2025
Our annual symposium brings together researchers from across the network to showcase diverse and innovative work.
BHF CRE early career mentoring event
Our Early Career Researcher (ECR) Working Group hosted a mentoring event to connect postdoctoral researchers and final-year PhD students with experienced mentors.
Read more: 2025 events 2026 events
What's new
Study identifies immune–metabolic pathway as potential target in diabetic heart disease
19 March 2026
Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.
Cardiovascular Innovation Awards kick-off event inspires researchers to explore translation and commercialisation pathways
12 February 2026
The BHF Oxford Centre of Research Excellence (BHF Oxford CRE) launched the Cardiovascular Innovation Awards (CIA) with an energising kick off event at the Saïd Business School, University of Oxford on Friday 6th February.
The Oxford-Harrington Rare Disease Centre Advances Discovery of Therapies for Friedreich’s Ataxia (FA)
9 February 2026
Many congratulations to BHF Oxford CRE's PI Chris Toepfer who is one of the five Oxford researchers awarded philanthropic funding from the FA Alliance Innovation Fund to support development of novel therapeutics.
BHF Oxford CRE Annual Symposium 2025
26 November 2025
The Oxford cardiovascular community came together at the Town Hall on Wednesday 26th November for the BHF Oxford CRE annual symposium, a chance to share diverse and exciting research from across the network.